CCK₂receptor antagonists

This publication has 40 references indexed in Scilit:

• Controlled Modification of Acidity in Cholecystokinin B Receptor Antagonists: N-(1,4-Benzodiazepin-3-yl)-N ‘-[3-(tetrazol-5-ylamino)phenyl]ureas
  Journal of Medicinal Chemistry, 1996
• A Double-Blind, Placebo-Controlled Study of a CCK-B Receptor Antagonist, CI-988, in Patients With Generalized Anxiety Disorder
  Journal of Clinical Psychopharmacology, 1995
• Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers
  Biological Psychiatry, 1995
• Potent, selective, water-soluble benzodiazepine-based CCKB receptor antagonists that contain lipophilic carboxylate surrogates
  Bioorganic & Medicinal Chemistry Letters, 1995
• A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder
  Biological Psychiatry, 1995
• Measurement of central nervous system activity of systemically administered CCKB receptor antagonists by ex vivo binding
  European Journal of Pharmacology, 1994
• High-Affinity and Potent, Water-Soluble 5-Amino-1,4-benzodiazepine CCKB/Gastrin Receptor Antagonists Containing a Cationic Solubilizing Group
  Journal of Medicinal Chemistry, 1994
• Development of 1,4-benzodiazepine cholecystokinin type B antagonists
  Journal of Medicinal Chemistry, 1993
• A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus
  Science, 1985
• Distinct cholecystokinin receptors in brain and pancreas.
  Proceedings of the National Academy of Sciences, 1980